Ahren Innovation Capital
Deep science investor backing brain and AI, genetics, space, robotics and energy companies.
- Venture capital
- London
- Type
- Venture capital
- Based in
- London
- Stages
- Series A, Series B+, Growth
- Sector focus
- AI & Data, Climate & Energy, Deeptech, Hardware & Robotics
- Cheque size
- Above €3M
- Fund size
- $253m
- Founded
- 2017
- Website
- ahreninnovationcapital.com
Ahren Innovation Capital is a deep tech venture firm set up in 2017 by Alice Newcombe-Ellis with a group of science partners whose work underpins technologies such as Illumina sequencing chemistry. It is based in Cambridge and London, and its first fund closed at about $253m with backers including Unilever, Aviva and Sky.
The firm invests in four domains: brain and AI, genetics and platform technologies, space and robotics, and planet and efficient energy. It describes itself as patient capital and both invests in and helps build companies, from early rounds through to later stages. Portfolio companies include Bicycle Therapeutics and Nu Quantum.
← All investors · Is this your organisation? Request an update
More investors in the directory
The Craftory
Purpose-driven consumer packaged goods brands with category-changing potential
Symvan Capital
EIS and SEIS funds backing B2B SaaS and technology companies from seed to exit
Grafton Capital
Growth capital for European software, AI and tech-enabled businesses
Blackfinch Ventures
EIS and VCT investment in early and growth-stage UK technology businesses
The Conduit Connect
Impact-led UK startups from pre-seed to Series A in climate, health and financial resilience
TrueSight Ventures
Angel-sized cheques at pre-seed and seed, sector-agnostic, into technology companies
Subscribe to Newsletter
Join me on this exciting journey as we explore the boundless world of web design together.